Methenamine hippurate - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for methenamine hippurate and what is the scope of patent protection?

Methenamine hippurate is the generic ingredient in three branded drugs marketed by Ss Pharma, Aurobindo Pharma Ltd, Impax Labs Inc, Jubilant Cadista, Micro Labs, Novast Labs, and Alvogen, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for methenamine hippurate. Nine suppliers are listed for this compound.

Summary for methenamine hippurate

US Patents:	0
Tradenames:	3
Applicants:	7
NDAs:	7
Drug Master File Entries:	10
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	48
Clinical Trials:	6
Patent Applications:	3,013
Drug Prices:	Drug price trends for methenamine hippurate
What excipients (inactive ingredients) are in methenamine hippurate?	methenamine hippurate excipients list
DailyMed Link:	methenamine hippurate at DailyMed

See drug prices for methenamine hippurate

Recent Clinical Trials for methenamine hippurate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Texas Southwestern Medical Center	Phase 4
Washington University School of Medicine	Phase 4
VU University Medical Center	Phase 4

See all methenamine hippurate clinical trials

Medical Subject Heading (MeSH) Categories for methenamine hippurate

Anti-Infective Agents, Urinary

Anatomical Therapeutic Chemical (ATC) Classes for methenamine hippurate

J01XX	Other antibacterials
J01X	OTHER ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for methenamine hippurate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Jubilant Cadista	METHENAMINE HIPPURATE	methenamine hippurate	TABLET;ORAL	217675-001	Dec 1, 2023	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novast Labs	METHENAMINE HIPPURATE	methenamine hippurate	TABLET;ORAL	210068-001	Nov 27, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Ltd	METHENAMINE HIPPURATE	methenamine hippurate	TABLET;ORAL	205661-001	Jul 5, 2016	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.